Posted inDiet and Nutrition Magazines Obesity Ozempic (Drug) Semaglutide (Drug) Television Weight Oprah Says She Is on a Weight Loss Drug and ‘Done With the Shaming’ Ms. Winfrey has spent decades as a dominant figure in the country’s conversations about weight bias and dieting. Posted by By Mario AnzuoniReuters
Posted inDrugs (Pharmaceuticals) Eli Lilly and Company Health Insurance and Managed Care Novo Nordisk A/S Obesity Ozempic (Drug) Prices (Fares, Fees and Rates) Semaglutide (Drug) Tirzepatide How Much Do Ozempic and Wegovy Cost? Not What You Think. Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem. Posted by By Gina Kolata
Posted inHealth Insurance and Managed Care Medicare Novo Nordisk A/S Obesity Semaglutide (Drug) Suits and Litigation (Civil) Lawsuit Challenges Insurance Restrictions on Weight Loss Drugs Like Wegovy Many employers and government programs won’t cover costly obesity medications. A lawsuit is challenging one such policy. Posted by By Rebecca Robbins
Posted inDenmark Diabetes Drugs (Pharmaceuticals) Economic Conditions and Trends Gross Domestic Product Novo Nordisk A/S Ozempic (Drug) Semaglutide (Drug) Wegovy Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth. Posted by By Eshe Nelson